Colorectal Cancer Therapeutics strategies and Product Pipeline Review 2017

Pune, India, 13th October 2017: WiseGuyReports announced addition of new report, titled “Colorectal Cancer Drug Development Pipeline Review, 2017”.

Pune, India - October 13, 2017 /MarketersMedia/ —

Summary
This report provides an overview of the colorectal cancer pipeline landscape. The report provides comprehensive information on the therapeutics under development and key players involved in therapeutic development for anal, rectal and colorectal cancer, and features dormant and discontinued projects.

Anal cancer starts in the anus. Symptoms include rectal bleeding, rectal itching, a lump or mass at the anal opening, pain or a feeling of fullness in the anal area, narrowing of stool, pain or a feeling of fullness in the anal area

GET SAMPLE REPORT @ https://www.wiseguyreports.com/sample-request/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Rectal cancer affects the lower part of the colon, which connects the large bowel to the anus. The common signs and symptoms of rectal cancer include a change in bowel habits, diarrhea, constipation, or feeling that the bowel does not empty completely, blood, either bright red or very dark in the stool, stools that are narrower than usual, general abdominal discomfort such as frequent gas pains, bloating, fullness or cramps, weight loss with no known reason, constant tiredness and vomiting.

Finally, colorectal cancer is a cancer that starts in the colon or the rectum. Colorectal cancers begin as a growth called a polyp on the inner lining of the colon or rectum. Symptoms include abdominal pain and tenderness in the lower abdomen, blood in the stool, diarrhea, constipation, change in bowel habits, narrow stools and weight loss with no known reason.

The size of these pipelines ranges from 10 products in rectal cancer to 581 products in colorectal cancer. Across all three of these indications, however, kinases, immune-related proteins, DNA-related proteins and viral proteins are common targets, closely reflecting the current treatment landscape of these diseases.

Scope
- Which companies are the most active within the pipeline for colorectal cancer therapeutics?
- Which pharmaceutical approaches are the most prominent at each stage of the pipeline and within each indication?
- To what extent do universities and institutions play a role within this pipeline, compared to pharmaceutical companies?
- What are the most important R&D milestones and data publications to have happened in the field of colorectal cancer?

Reasons to buy
- Understand the overall pipeline, with an at-a-glance overview of all products in therapeutic development for each indication
- Assess the products in development in granular detail, with an up-to-date overview of each individual pipeline program in each indication, and a comprehensive picture of recent updates and milestones for each
- Analyze the companies, institutions and universities currently operating in the pipeline, and the products being fielded by each of these
- Understand the composition of the pipeline in terms of molecule type, molecular target, mechanism of action and route of administration

Table of Content: Key Points
1 Table of Contents 4
1.1 List of Tables 5
1.2 List of Figures 10
2 Introduction 11
2.1 Colorectal Cancer Report Coverage 11
2.2 Anal Cancer - Overview 11
2.3 Rectal Cancer - Overview 11
2.4 Colorectal Cancer - Overview 11
3 Therapeutics Development 12
3.1 Anal Cancer 12
3.2 Rectal Cancer 16
3.3 Colorectal Cancer 18
4 Therapeutics Assessment 56
4.1 Anal Cancer 56
4.2 Rectal Cancer 63
4.3 Colorectal Cancer 71
5 Companies Involved in Therapeutics Development 100
5.1 Anal Cancer 100
5.2 Rectal Cancer 108
5.3 Colorectal Cancer 114
6 Dormant Projects 241
6.1 Anal Cancer 241
6.2 Rectal Cancer 241
6.3 Colorectal Cancer 242
7 Discontinued Products 261
7.1 Anal Cancer 261
7.2 Colorectal Cancer 261
8 Product Development Milestones 265
8.1 Anal Cancer 265
8.2 Rectal Cancer 278
8.3 Colorectal Cancer 280
…Continued

ACCESS REPORT @ https://www.wiseguyreports.com/reports/2385276-colorectal-cancer-drug-development-pipeline-review-2017

Get in touch:
LinkedIn: www.linkedin.com/company/4828928
Twitter: https://twitter.com/WiseGuyReports
Facebook: https://www.facebook.com/Wiseguyreports-1009007869213183/?fref=ts

Contact Info:
Name: NORAH TRENT
Email: Send Email
Organization: WISEGUY RESEARCH CONSULTANTS PVT LTD
Address: Office No. 528, Amanora Chambers
Phone: +91 841 198 5042

Source URL: https://marketersmedia.com/colorectal-cancer-therapeutics-strategies-and-product-pipeline-review-2017/250073

For more information, please visit http://www.wiseguyreports.com

Source: MarketersMedia

Release ID: 250073

More News From 24-7 Reporters

Iran rebuffs Trump's call for OPEC to increase oil output

Jun 20, 2018

VIENNA — Iran lashed out Tuesday against U.S. President Donald Trump's call on OPEC to increase oil production and limit global energy prices, saying the cartel "is not an American organization." The OPEC oil ministers began arriving in Vienna on Tuesday ahead of their official meeting Friday, when they will also confer with Russia, a non-OPEC country that since late 2016 has cooperated with the cartel to limit production. Analysts expect the group to consider an increase in production of about 1 million barrels a day, ending the output cut agreed on in 2016. The cut has since then pushed...

The Latest: Hungary asked to delay vote on 'Stop Soros' bill

Jun 20, 2018

BRUSSELS — The Latest on the immigration debate in Europe (all times local): 9:00 p.m. Experts within the Council of Europe are asking Hungarian lawmakers to delay passage of a bill that would penalize people who assist refugees with up to a year in prison. Venice Commission chief Gianni Buquicchio told Hungarian Foreign Minister Peter Szijjarto on Monday that Hungary's parliament should wait until the commission publishes recommendations on the so-called "Stop Soros" bill or at least take into account the preliminary views already shared with Hungarian officials. The pending bill is named for Hungarian-American financier George Soros, who Hungary's...

Italy's interior minister turns gaze to 'Roma question'

Jun 20, 2018

ROME — Italy's hard-line interior minister, who recently sparked a multinational showdown by refusing entry to a Mediterranean Sea rescue boat packed with 630 migrants, is now taking aim at Italy's minority Roma community. Interior Minister Matteo Salvini told a Lombardy television station Monday that he wants to conduct a census or "registry" of Roma in Italy. Salvini, the leader of Italy's right-wing League party, insisted later the project's purpose wasn't to identify individual Roma. "I've asked the ministry to prepare a dossier on the Roma question in Italy," he told TeleLombardia, adding that the current situation of Roma, also...

Number of asylum-seekers in Europe plunges in 2017

Jun 20, 2018

BRUSSELS — The European Union's asylum office says the number of people applying for international protection in Europe has plunged but remains higher than before 2015, when more than one million migrants entered, many fleeing the war in Syria. EASO said in an annual report Monday that 728,470 application requests were made for international protection in 2017, compared to almost 1.3 million applications the previous year. It says around 30 percent of the applicants come from conflict-torn countries such as Syria, Afghanistan and Iraq. EASO says there is a still a backlog: more than 950,000 applications were still awaiting a...

Prada redefines youthful elegance with psychedelic flair

Jun 20, 2018

MILAN — Youthful designers injected energy into the third day Sunday of Milan Fashion Week menswear previews for next spring and summer. While the topics of generational and creative change at some of the most-established Milan fashion houses were running in the background, young brands carved out their own space to grow by their own rules. Some highlights from Sunday's shows, including Milan mainstay Prada alongside younger brands Palm Angels, MSGM, Sunnei and Korean newcomers BESFXXK. ___ PRADA BASICS Miuccia Prada says she was "trying to do elegant in a new young way" with her latest menswear collection. At Prada,...

Sign up now!

About Us

24-7 Reporters publishes up-to-the-minute news 24 hours a day, 7 days a week. Our certified reporters are among the most experienced, well-trained and talented across the globe, covering issues resonating progressives in every corner of the world.

Contact us: sales[at]24-7reporters.com